<?xml version="1.0" encoding="UTF-8"?>
<svg height="727.919" width="530.993531190099" xmlns="http://www.w3.org/2000/svg">
 <g style="fill:none;">
  <text svg_rhmargin="102.103" x="76.272,81.588,85.127,89.558,92.802,95.902,99.003,102.103" y="21.089000000000055" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:7.97px;font-style:italic;font-weight:normal;">Cancers </text>
  <text x="104.096,108.081,112.066,116.051" y="21.089000000000055" svg_rhmargin="120.036" style="fill:#000000;font-family:DPYECX+URWPalladioL-Bold;font-size:7.97px;font-style:NORMAL;font-weight:BOLD;">2019</text>
  <text svg_rhmargin="122.029" x="120.036,122.029" y="21.089000000000055" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:7.97px;font-style:NORMAL;font-weight:normal;">, </text>
  <text x="124.021,128.006" y="21.089000000000055" svg_rhmargin="131.991" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:7.97px;font-style:italic;font-weight:normal;">11</text>
  <text x="131.991,133.984,135.976,139.961,143.94600000000003,491.809,495.794,499.779,501.772,506.123,508.777,510.77,514.755" y="21.089000000000055" svg_rhmargin="518.74" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:7.97px;font-style:NORMAL;font-weight:normal;">, 47 20 of 27</text>
  <text x="76.535,81.047,86.128,90.142,94.156,97.113,101.98,108.18900000000001,110.77,116.319,122.446,125.759,128.34,133.421,137.252,142.8,148.928,154.842,161.05100000000002,163.632,166.945,172.859,177.727,180.308,188.783,194.331,198.345,201.302,207.511,210.052,213.405,221.311,225.62,228.201,233.749,237.13299999999998,239.714,247.62,253.727,257.741,260.698,263.655,266.236,271.317,276.398,278.939,281.54,286.621,291.702,296.783,301.864,304.405,307.006,310.319,316.233,321.101,323.681,326.639,332.553,335.937,341.485,345.499,354.472,359.553,362.866,365.823,371.371,377.28499999999997,379.866,383.25,387.081,392.63,401.603,404.184,411.388,414.345,417.303,423.217,426.174,430.686,435.767,438.724,442.037,446.05,451.131,454.089,457.046,461.354,463.895,469.545,475.093,480.83500000000004,483.416,487.724,493.638,499.187,507.662,512.529" y="55.95799999999997" svg_rhmargin="518.738" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">carried out around the world. As of April 19, 2018, the information from Clinicaltrails.gov showed</text>
  <text x="76.535,79.786,85.59,90.576,93.827,96.321,105.126,110.571,114.331,119.108,121.601,124.852,130.656,135.642,141.446,143.94,148.926,153.912,158.899,161.392,168.462,176.221,182.883,185.376,190.94,194.261,198.021,202.798,205.7,210.686,213.937,218.714,224.808,227.31,231.538,234.79,240.803,246.896,249.788,254.565,258.794,261.297,269.614,274.391,278.15,282.92699999999996,285.42,291.434,297.238,303.331,308.108,311.867,317.412,322.857,325.759,331.563,337.108,339.601,344.029,346.931,349.833,355.637,358.539,362.967,367.953,370.85499999999996,373.348,376.599,380.538,383.44,388.427,391.329,395.558,398.05,400.952,406.756,409.249,418.055,423.041,428.845,434.39000000000004,436.883,442.977,445.879,449.02,452.341,457.118,460.877,465.654,471.458,474.709,477.202,481.63,487.075,493.089,498.893,502.144,506.083,508.985,513.762,517.99" y="69.46799999999996" svg_rhmargin="520.483" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">that more than 270 CAR T-related studies were undergoing clinical trials in many different countries.</text>
  <text x="76.535,82.592,87.548,91.751,96.499,102.556,105.054,110.466,116.235,118.734,121.965,127.735,132.483,134.991,139.392,142.277,145.161,150.93,153.815,158.216,163.173,166.058,168.555,173.968,179.945,183.177,187.578,192.99,201.743,206.492,210.695,213.193,218.605,221.90599999999998,224.404,231.432,239.144,245.76600000000002,248.264,254.341,256.839,260.07,265.84,270.588,274.503,279.46,285.417,289.828,292.306,294.805,299.008,303.756,309.357,314.105,318.02,322.977,325.86199999999997,328.359,331.244,339.997,345.955,351.367,355.283,358.514,363.471,369.24,372.47200000000004,374.969,378.27,383.227,387.628,390.86,396.272,400.188,404.39099999999996,406.899,415.166,419.914,423.651,428.399,430.897,434.198,439.611,445.588,451.357,457.414,459.892,463.005,468.516,473.929,477.84499999999997,480.342,485.091,490.206,495.162,503.915,509.873,512.757,517.505" y="82.97699999999998" svg_rhmargin="519.983" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">Based on the clinical outcomes of CAR T therapy, several important factors were found. For example,</text>
  <text x="76.535,79.437,82.758,85.251,88.502,94.306,99.083,101.576,107.57,112.556,115.807,118.709,123.486,129.29,132.541,136.77,139.262,147.58,150.482,153.733,159.537,162.02,167.824,172.601,181.406,186.393,189.644,195.089,197.991,203.436,208.981,211.883,216.311,218.804,227.609,232.596,235.498,238.4,243.944,249.748,254.735,260.539,264.967,267.869,272.645,276.87399999999997,279.367,285.46,288.362,294.456,296.948,302.753,308.198,311.44899999999996,313.942,318.928,323.356,327.784,332.56,338.554,341.80499999999995,344.298,347.2,352.745,361.551,367.544,373.348,378.793,384.887,389.663,395.657,398.559,403.336,406.587,409.489,414.934,420.738,423.221,428.736,433.513,436.834,442.279,446.038,450.815,453.308,456.559,460.319,465.096,470.082,473.333,482.139,486.916,492.72,495.971,498.464,506.781,509.683,512.934" y="96.48699999999997" svg_rhmargin="518.738" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">if the patients with hematologic malignancies did not accept lymphodepletion before treatment with</text>
  <text x="76.535,83.74,91.646,98.434,101.157,107.386,110.11,114.622,119.489,122.446,125.403,129.712,132.253,135.047,138.36,144.274,149.141,154.791,157.515,165.99,171.538,177.666,180.623,186.832,189.555,193.864,199.991,203.192,206.576,211.444,215.458,218.181,223.922,228.79,232.804,238.454,241.177,245.486,250.353,254.367,257.324,262.873,269.0,273.309,276.043,283.247,290.035,295.37,298.094,303.175,309.089,315.298,318.021,322.889,328.63,333.498,339.412,342.135,345.092,348.049,351.433,356.301,359.685,362.998,368.912,372.753,377.62,382.701,386.014,390.882,396.796,399.753,405.667,411.31699999999995,414.041,418.908,424.65,429.517,435.431,438.744,443.053,445.594,449.383,457.838,463.387,471.861,476.729,482.47,487.338,490.62,493.161,495.945,499.258,505.172,510.04,513.871" y="109.99599999999998" svg_rhmargin="518.739" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">CAR T cells, they would suffer very serious CRS and even life-threatening events. However, there</text>
  <text x="76.535,79.492,83.801,86.87,91.178,94.491,97.448,100.405,103.362,106.431,112.345,117.893,120.973,125.281,130.931,135.24,138.553,143.42,152.393,157.474,160.787,163.744,168.256,171.325,175.156,180.023,185.765,188.722,193.589,202.064,205.133,210.682,214.06599999999997,217.145,220.457,226.371,231.239,234.308,239.175,242.376,248.524,253.036,258.117,262.629,268.279,271.348,276.429,282.343,288.552,291.621,295.929,301.01,304.394,309.262,312.574,318.224,321.304,326.852,330.236,333.305,340.509,348.415,355.20300000000003,358.272,364.501,367.57,370.883,376.797,381.665,385.679,390.76,396.867,402.517,405.586,408.543,414.457,417.526,423.633,428.714,432.027,434.984,439.852,445.766,449.079,453.38800000000003,456.466,464.941,467.898,471.211,477.125,480.194,486.403,489.36,492.561,495.945,500.813,504.644,509.511,515.425" y="123.505" svg_rhmargin="518.738" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">is still no systematic review of the efﬁcacy and safety of CAR T therapy in patients with different</text>
  <text x="76.535,79.838,85.948,94.894,100.426,104.428,108.724,111.257,114.368,120.579,126.475,132.585,136.881,139.414,141.917,145.22,151.116,154.065,158.361,160.863,165.159,168.462,174.572,180.763,186.39600000000002,188.898,195.028,197.977,200.925,205.221,207.714,211.017,216.913,219.862,224.158,226.66,232.263,235.212,240.278,246.174,251.80700000000002,254.31,257.684,263.216,267.218,269.711,273.014,278.911,283.764,286.267,292.396,296.399,300.695,303.998,306.5,309.803,312.752,321.698,326.551,329.044,334.647,340.28,342.783,348.892,353.188,356.137,362.033,367.666,370.169,379.116,383.969,387.272,392.338,395.712,400.778,406.675,411.741,414.689,420.323,424.619,427.567,431.863,434.396,436.898,441.194,447.304,452.907,458.54,462.36,467.892,474.002,480.091,482.594,487.66,493.556,498.622,501.571,507.204,511.5,514.449" y="137.015" svg_rhmargin="518.745" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">tumors. Thus, this study ﬁlls this blank for the ﬁrst time by using meta-analysis, subgroup analysis</text>
  <text x="76.535,81.516,87.315,93.402,95.892,104.689,109.461,112.709,117.691,121.008,124.764,129.536,135.075,138.831,143.603,147.827,152.051,154.951,160.39,166.188,168.679,173.66,179.459,184.44,187.339,192.878,197.102,200.001,204.226" y="150.524" svg_rhmargin="206.717" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">and meta-regression analysis.</text>
  <text x="97.735,103.822,109.47200000000001,112.378,117.337,123.129,128.088,130.924,136.452,141.411,144.246,150.038,155.68800000000002,158.584,161.775,167.567,172.435,175.341,183.206,189.872,196.66000000000003,199.557,204.516,210.308,216.517,219.423,226.506,233.172,239.96,242.856,248.283,251.66699999999997,254.573,261.656,269.44,276.228,279.124,285.353,288.259,291.45,297.243,301.988,305.88,310.839,316.824,322.474,325.381,328.216,334.13,337.026,343.011,347.97,351.161,353.996,358.742,364.534,367.725,372.03400000000005,374.94,383.293,386.128,389.319,395.233,398.129,404.216,407.051,410.313,413.575,418.321,422.04,426.786,432.578,435.89099999999996,438.787,441.978,447.983,456.834,462.261,466.153,470.339,472.88,475.928,484.281,489.149,492.045,495.307,500.733,506.739,512.531" y="164.034" svg_rhmargin="518.74" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">By analyzing the ORR and CRR of CAR T therapy in patients with different tumors, we found</text>
  <text x="76.535,79.66,85.333,90.19,93.435,95.783,98.909,104.582,109.34899999999999,111.708,115.34,119.988,124.089,129.951,135.266,140.939,145.039,149.80599999999998,152.155,155.967,160.824,163.949,168.716,171.065,179.246,184.103,188.323,190.682,194.782,197.559,202.973,208.646,211.423,214.618,217.395,221.694,226.551,232.224,235.349,238.126,243.66,246.009,251.682,254.458,259.873,265.546,270.193,274.12399999999997,276.474,279.668,284.983,288.914,291.263,297.125,301.982,305.107,307.884,312.532,318.205,321.33,325.55,327.909,336.09,338.866,341.992,347.785,350.133,355.806,360.454,369.122,373.979,377.104,382.419,385.196,390.511,395.925,398.702,403.121,405.469,414.138,418.995,421.772,424.548,429.963,435.636,440.492,446.165,450.465,453.242,457.89,462.11,464.468,468.768,474.083,482.751,488.613,493.47,497.103,501.751,507.832,510.181,513.306" y="177.543" svg_rhmargin="518.74" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">that the response rate was significantly higher for patients with hematologic malignancies compared to</text>
  <text x="76.236,81.987,86.751,89.817,92.541,97.1,102.665,105.731,109.871,111.892,119.917,122.641,125.707,131.38899999999998,133.4,137.423,142.637,145.361,148.085,154.05,156.071,164.575,169.339,172.063,174.787,180.099,185.664,190.428,195.993,200.211,202.935,207.495,211.517,213.958,216.789,222.569,226.133,230.692,236.091,238.815,244.029,249.799,253.939,255.95,259.973,263.038,268.808,274.657,277.381,281.94,286.08,288.101,292.123,297.893,303.205,308.516,313.075,317.098,320.164,324.723,330.688,332.71,335.775,341.34,346.105,349.288,351.299,358.104,365.583,372.105,374.126,380.111,382.122,385.188,390.753,395.312,399.052,403.816,409.567,414.995,417.016,421.039,424.104,426.828,429.552,432.39300000000003,434.415,439.98,444.744,450.709,452.721,461.225,465.989,471.554,476.98199999999997,479.004,484.754,488.318,493.532,498.814,501.538,506.097,514.601" y="191.05200000000002" svg_rhmargin="518.741" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">patients with solid malignancies. Previous studies suggested that CAR T therapy still had many problems</text>
  <text x="76.535,81.494,87.286,93.495,97.326,101.716,107.508,112.467,115.302,118.138,122.883,128.675,134.204,138.949,143.258,147.079,150.341,155.767,159.781,163.612,169.597,174.556,177.747,180.582,185.328,191.12,194.311,198.62,202.45,210.803,213.639,216.829,222.743,226.565,230.751,236.178,239.013,241.848,248.05700000000002,251.888,260.739,265.698,268.533,271.368,276.896,282.688,287.647,293.44,297.829,300.665,305.41,309.597,312.138,316.334,320.521,326.526,330.916,336.83,340.662,345.621,349.93,353.76,358.719,364.511,367.702,370.537,376.065,380.811,386.72499999999997,390.546,396.166,401.125,403.96,406.795,412.882,417.841,421.032,423.867,429.293,435.085,437.626,441.833,445.024,451.029,459.88,465.307,469.321,473.142,476.332,480.224,485.183,488.445,491.707,494.542,498.932,504.46,507.296,513.088" y="204.562" svg_rhmargin="518.738" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">and challenges for patients with solid malignancies, such as antigen validation, tumor trafficking</text>
  <text x="76.535,81.455,87.202,93.362,95.691,98.504,104.251,107.487,110.3,113.113,116.279,120.14,125.06,128.226,131.039,136.423,142.17,144.69099999999997,147.019,150.185,156.144,164.925,170.309,174.291,176.61,182.357,187.066,190.231,194.94,198.63,204.014,209.498,214.197,219.943,224.652,227.465,230.631,235.016,237.53699999999998,239.866,244.786,250.533,256.693,259.012,263.932,269.8,272.129,274.942,283.723,292.505,298.463,304.21,309.594,313.748,319.706,325.645,331.583,335.263,339.972,344.125,348.279,351.092,356.668,361.497,363.826,372.608,375.421,379.776,383.456,388.84,393.548,399.295,404.871,407.683,411.363,416.747,422.494,431.276,435.984,441.731,445.018,447.347" y="218.07100000000003" svg_rhmargin="450.704" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">and infiltration, tumor heterogeneity, and an immunosuppressive microenvironment [</text>
  <text x="450.585,455.447" y="218.07100000000003" svg_rhmargin="460.428" style="fill:#0875b7;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">27</text>
  <text x="460.308" y="218.07100000000003" svg_rhmargin="462.829" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">,</text>
  <text x="462.708,467.57" y="218.07100000000003" svg_rhmargin="472.551" style="fill:#0875b7;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">66</text>
  <text x="472.431" y="218.07100000000003" svg_rhmargin="474.952" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">,</text>
  <text x="474.831,479.693" y="218.07100000000003" svg_rhmargin="484.674" style="fill:#0875b7;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">67</text>
  <text x="484.554,487.79,490.31100000000004,493.245,499.304,505.051,509.759,513.913" y="218.07100000000003" svg_rhmargin="518.742" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">]. These</text>
  <text x="76.236,82.174,85.854,91.238,96.693,99.506,104.214,112.996,117.271,119.609,124.53,130.276,136.436,138.776,143.131,148.878,153.798,156.611,159.424,164.132,169.879,175.364,180.072,184.347,186.676,189.489,194.197,200.357,202.696,205.862,211.367,213.706,219.644,225.028,230.412,234.394,236.724,240.414,245.122,249.276,255.214,260.598,266.345,270.499,275.32800000000003,277.657,281.519,286.439,289.605,294.434,296.773,302.157,305.514,307.853,313.792,318.712,321.878,324.691,329.399,335.146,338.312,342.587,344.915,353.203,356.016,359.182,365.05,367.388,371.542,376.926,379.739,382.552,388.71200000000005,391.051,399.833,404.753,407.566,410.379,415.864,421.61,426.53,432.277,436.633,439.446,444.154,448.308,450.829,453.157,458.078,463.824,469.98400000000004,472.324,477.708,483.666,487.648,489.988,493.668,498.376,502.53,508.488,511.301,514.467" y="231.58100000000002" svg_rhmargin="518.742" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">problems and challenges led to poor response rate of patients with solid malignancies, and our results</text>
  <text x="76.535,79.739,85.639,89.462,92.597,98.287,102.949,106.892,109.228,113.54,118.871,124.561,127.765,130.55,134.374,143.069,147.73,153.82999999999998,156.166,158.951,162.085,164.58100000000002,167.516,173.495,178.157,182.27,185.055,191.034,195.696,199.809,202.305,204.641,207.775,213.465,216.25,220.483,222.809,226.922,230.056,235.956,241.935,247.486,249.822,254.693,260.383,265.254,268.04,273.47,278.342,283.003,289.103,291.439,294.573,300.263,305.04499999999996,307.381,315.107,321.656,328.325,330.66,335.532,341.222,347.322,349.647,356.605,363.153,369.822,372.157,377.488,380.812,383.148,390.106,397.753,404.42199999999997,406.757,412.877,415.212,418.347,424.037,428.699,432.522,437.393,443.273,448.824,451.149,453.934,459.744,462.08,467.96,472.831,475.966,478.751,483.413,489.103,492.237,496.47,498.806,507.012,509.797,512.931" y="245.09000000000003" svg_rhmargin="518.741" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">further confirmed it. Besides, this study analyzed the ORR and CRR of CAR T therapy in patients with</text>
  <text x="76.535,82.568,85.378,88.612,91.845,96.548,100.225,104.929,110.67,113.953,116.28,122.313,125.546,129.897,134.601,137.411,140.342,142.669,151.442,156.357,159.167,161.977,167.457,173.198,178.113,183.854,188.205,191.015,195.719,199.98999999999998,202.316,207.766,213.36599999999999,215.692,221.645,225.795,228.605,234.346,239.946,242.273,251.046,255.749,258.912,263.827,267.061,271.976,277.717,282.632,285.442,290.921,295.071,297.881,302.152,304.479,309.394,315.135,321.289,323.616,327.765,333.718,339.167,344.646,348.323,353.701,359.654,365.707,368.034,372.949,378.69,383.606,386.416,391.895,396.045,398.855,403.004,405.522,408.464,414.517,420.258,425.082,427.409,431.086,435.789,439.939,445.892,448.702,451.985,454.312,458.663,464.042,469.783,473.016,475.826,479.684,488.457,493.16,499.314,501.641,504.804,510.545,515.46" y="258.59900000000005" svg_rhmargin="518.744" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">different B-cell malignancies by using meta-analysis and subgroup analysis. The result confirmed that</text>
  <text x="76.535,83.375,90.892,97.447,99.782,105.797,108.133,111.215,116.808,121.391,125.149,129.938,135.718,141.17399999999998,143.51,149.103,153.892,159.888,162.214,167.121,169.456,174.794,178.376,182.959,187.748,190.947,193.282,196.864,201.447,205.49,211.27,216.51,222.103,226.147,230.84699999999998,233.173,236.931,241.72,244.801,249.50099999999998,251.837,254.987,260.228,264.104,266.439,272.219,277.008,280.089,282.827,287.41,293.004,296.085,300.246,302.581,310.648,313.385,316.467,322.178,324.514,332.03,337.909,343.787,346.23999999999995,348.575,356.612,364.659,370.655,372.981,377.77,383.363,389.359,391.694,398.534,404.412,410.29,412.743,415.079,420.388,426.188,429.387,431.722,434.46,437.659,439.995,445.588,450.377,456.373,458.708,464.488,469.729,474.969,478.84499999999997,481.181,484.753,489.335,493.378,499.158,504.398,509.992,514.035" y="272.10900000000004" svg_rhmargin="518.736" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">CAR T therapy had a great response rate for patients with ALL, NHL and CLL, but it had poor response</text>
  <text x="76.535,80.351,85.212,88.341,93.113,95.454,98.652,103.972,107.907,110.248,116.116,120.978,124.106,126.886,131.539,137.217,140.345,144.569,146.911,155.1,157.88,161.008,166.806,169.147,177.317,183.284" y="285.61800000000005" svg_rhmargin="185.775" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">rate for patients with HL.</text>
  <text x="97.795,104.024,109.938,114.806,118.373,122.885,128.433,137.406,146.379,151.927,157.84099999999998,161.408,165.717,168.674,174.883,179.751,183.317,188.185,191.396,194.77,199.637,204.149,207.462,211.771,215.347,218.66,224.574,229.655,232.968,236.535,241.047,246.128,252.255,256.564,261.431,267.64,271.207,276.826,282.476,286.043,293.248,301.154,307.942,311.509,317.738,321.305,325.817,330.684,333.641,336.598,340.90700000000004,344.474,347.431,353.345,357.857,360.814,366.942,373.151,378.018,384.227,387.794,394.999,401.787,407.122,409.663,413.239,421.684,427.019,430.585,435.666,441.58,447.789,451.356,457.585,463.794,469.129,471.67,475.236,481.466,487.38,492.248,495.814,504.787,509.868,512.825" y="299.128" svg_rhmargin="518.739" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">The common side effects that caused by CAR T cells included CRS, NS and TLS. The main</text>
  <text x="76.535,80.675,86.103,94.724,100.592,103.775,109.106,117.72699999999999,120.109,125.44,128.691,131.073,137.995,144.517,149.643,152.025,154.866,160.549,164.884,167.725,173.612,179.577,184.254,190.219,192.602,195.853,200.53,206.046,210.723,213.847,216.288,218.689,227.31,232.739,237.621,240.462,245.89,248.731,253.613,256.054,258.456,264.138,268.814,273.696,279.661,284.543,288.878,294.56,299.237,301.678,304.089,308.971,314.653,319.984,323.655,328.332,333.37,336.211,341.092,343.53299999999996,345.945,351.627,356.509,362.396,366.536,371.212,376.094,378.476,383.358,389.04,395.005,397.388,402.904,408.235,416.856,419.697,422.88,425.721,431.404,436.832,439.27299999999997,441.675,445.355,450.032,455.714,460.596,463.437,465.819,471.785,477.213,481.353,484.604,490.491,496.174,500.509,503.691,506.533,511.863,517.546" y="312.637" svg_rhmargin="519.987" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">symptom of CRS included fever, myalgia, headache, anorexia, nausea and vomiting, renal dysfunction,</text>
  <text x="76.535,80.87,86.201,91.082,96.511,102.398,105.239,110.57,116.438,121.319,124.502,130.185,134.51,136.951,139.431,145.113,150.541,156.409,161.74,164.923,169.599,175.282,179.421,182.262,187.593,193.275,195.716,198.196,202.531,207.413,213.28,216.122,218.963,221.804,226.686,230.542,234.867,237.308,239.788,242.629,247.306,252.187,257.616,260.05699999999996,262.537,267.418,273.101,279.066,281.546,287.414,293.301,296.142,304.763,310.094,315.776,320.658,324.514,329.942,332.423,337.099,343.065,347.741,356.362,361.244,363.685,366.77,372.755,378.437,383.113,385.594,394.215,399.096,401.938,407.62,410.1,414.239,419.668,428.289,434.157,437.34,442.67,451.291,453.771,459.102,462.35299999999995,464.823,472.937,478.063,480.542,483.383,489.066,493.401,496.242,502.129,508.094,512.771" y="326.146" svg_rhmargin="518.736" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">coagulopathy, hypotension, capillary, leak, and pulmonary edema. The main symptom of NS included</text>
  <text x="76.535,80.989,86.467,92.306,95.647,101.696,105.95,108.869,114.347,120.186,122.694,125.192,131.322,134.662,139.117,143.922,146.842,149.76100000000002,152.249,157.265,163.295,169.133,174.15,178.403,181.323,186.339,188.847,191.345,197.385,203.223,207.016,211.821,216.075,222.104,227.582,233.421,237.674,240.594,246.262,251.068,254.408,260.247,265.053,269.306,273.56,276.068,278.556,283.572,289.411,295.541,298.039,302.293,307.098,310.018,315.034,321.083,324.865,329.671,333.925,336.433,339.523,347.328,353.167,359.29699999999997,361.794,365.065,370.904,375.709,378.197,387.056,392.072,394.991,400.83,403.328,407.582,413.16,422.019,428.048,431.319,436.796,445.654,448.143,453.62,456.961,459.459,465.609,471.739,477.006,479.494,482.413,488.252,492.706,495.626,501.675,507.805,512.61" y="339.656" svg_rhmargin="518.74" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">confusion, B-cell aphasia, unresponsive-ness, and seizures. And the main symptom of TLS included</text>
  <text x="76.535,82.217,87.646,93.513,98.19,101.969,107.856,111.712,114.553,118.888,123.565,132.186,135.027,139.909,142.35,144.732,150.414,155.843,161.71,166.387,170.244,175.672,180.554,183.395,188.071,196.693,199.534,204.415,206.856,209.238,214.921,220.349,226.217,230.894,234.75,240.618,246.3,251.631,255.771,261.638,267.321,272.202,275.385,280.062,288.683,291.524,296.406,298.847,301.229,306.11,311.793,317.758,320.111,325.793,331.222,337.09,342.42,346.755,351.637,354.478,358.813,363.49,372.111,374.952,379.834,382.186" y="353.165" svg_rhmargin="385.437" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">hyperuricemia, hyperkalemia, hyperphosphatemia, and hypocalcemia [</text>
  <text x="385.437,390.418" y="353.165" svg_rhmargin="395.399" style="fill:#0875b7;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">11</text>
  <text x="395.399,398.65,401.09099999999995,404.137,410.122,415.804,420.47999999999996,422.834,426.515,431.182,435.321,441.209,444.05,447.233,449.595,453.266,457.943,463.371,468.253,471.934,477.899,480.74,486.423,491.851,494.204,501.126,506.252,512.217" y="353.165" svg_rhmargin="518.739" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">]. The result regarding CSER</text>
  <text x="76.535,82.083,85.467,87.967,95.172,103.078,109.866,112.366,118.595,121.095,124.407,130.322,135.189,139.203,144.284,150.391,156.041,158.541,161.498,167.41199999999998,169.912,176.02,181.1,184.413,187.37,192.238,198.152,201.465,205.774,208.283,216.758,219.715,223.028,228.94199999999998,231.442,235.751,241.299,244.256,247.213,253.422,255.922,261.003,266.917,273.126,275.626,281.54,286.408,295.381,300.462,303.774,309.323,312.28,317.828,323.478,326.435,330.947,333.447,342.42,347.501,350.458,353.415,359.065,364.979,370.06,375.974,380.486,383.443,388.311,392.62,395.119,399.428,405.555,411.205,416.855,421.723,426.032,429.344,434.212,440.421,442.921,446.233,452.148,457.228,460.541,463.041,466.354,472.268,477.13599999999997,479.635,486.84,493.628,498.96299999999997,501.463,505.477,510.558,513.871" y="366.675" svg_rhmargin="518.739" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">of CAR T therapy in patients with solid and hematologic malignancies suggested that the CRS rate</text>
  <text x="76.117,84.467,89.474,93.71900000000001,96.202,100.447,103.361,108.928,114.755,117.669,123.726,128.172,133.178,139.005,142.269,145.183,150.75,153.233,159.06,161.973,167.54,173.368,178.163,182.11800000000002,184.601,187.936,193.402,197.357,199.84,205.858,210.864,214.128,217.042,221.838,227.665,230.929,235.174,237.657,246.008,248.921,252.185,258.012,260.496,266.323,271.119,279.96,284.966,288.23,293.697,296.61,302.077,307.644,310.558,315.003,317.486,326.327,331.333,334.247,337.161,342.728,348.555,353.561,359.388,363.834,366.747,371.543,375.788,378.272,382.717,388.184,397.025,403.042,408.048,411.823,416.619,422.73600000000005,425.22,428.484,433.95099999999996,436.434,442.451,447.457,450.721,453.635,458.431,464.258,467.522,471.767,474.241,482.591,485.504,488.768,494.59499999999997,497.079,501.324,506.791,509.704,512.618" y="380.184" svg_rhmargin="518.736" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">was signiﬁcantly higher for patients with hematologic malignancies compared to patients with solid</text>
  <text x="76.535,85.156,90.038,92.879,95.72,101.148,106.831,111.712,117.395,121.73,124.571,129.247,133.387,135.828,137.868,142.75,148.432,154.397,156.331,159.514,165.196,169.87199999999999,171.796,179.909,185.035,186.968,190.825,195.706,198.889,203.565,205.489,213.632,218.514,222.654,224.586,228.726,231.567,234.408,239.837,245.519,248.702,251.543,256.971,258.895,264.577,267.418,272.847,278.529,283.206,287.062,288.995,292.246,297.577,301.433,303.367,309.235,314.116,317.299,320.14,324.817,330.499,333.682,337.822,339.745,347.888,350.729,353.912,359.594,361.527,367.209,371.886,380.507,385.389,388.572,393.902,396.744,402.074,407.503,410.344,414.679,416.602,425.223,430.105,432.946,435.787,441.216,446.898,451.78,457.462,461.797,464.638,469.315,473.455,475.387,479.722,485.053,493.674,499.542,504.424,508.095,512.771" y="393.693" svg_rhmargin="518.736" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">malignancies, and the NS rate was slightly higher for patients with hematologic malignancies compared</text>
  <text x="76.535,79.848,85.396,89.105,95.212,100.293,103.606,106.563,111.431,117.345,120.658,124.967,128.665,137.14,140.097,143.41,149.32399999999998,153.033,157.342,162.89,165.848,168.805,175.014,178.712,187.685,192.766,195.723,198.68,204.33,210.245,215.326,221.24,225.752,228.709,233.576,237.885,240.426,247.163,253.392,259.306,264.174,268.482,273.35,277.049,280.89,285.757,290.066,296.194,299.151,302.463,306.77200000000005,310.471,314.983,320.531,326.445,332.593,336.607,345.58,350.448,356.657,360.366,363.678,369.593,374.674,377.98699999999997,381.685,384.998,390.912,395.78,399.489,405.596,410.677,413.99,416.947,421.814,427.729,431.041,435.35,439.059,447.534,450.491,453.804,459.71799999999996,463.417,469.331,474.199,483.172,488.253,491.565,497.114,500.071,505.619,511.269,514.226" y="407.203" svg_rhmargin="518.738" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">to patients with solid malignancies. These results conﬁrmed that the patients with hematologic</text>
  <text x="76.535,85.411,90.437,93.362,96.288,101.877,107.727,112.753,118.604,123.067,125.992,130.807,135.069,137.552,142.015,147.504,153.566,156.491,162.633,165.116,170.142,174.605,180.455,183.381,188.186,193.865,198.68,201.163,206.18900000000002,208.672,214.231,219.046,222.323,225.6,230.415,234.386,236.869,240.658,245.473,249.736,255.777,261.265,267.116,271.378,276.193,278.676,282.647,287.673,290.95,295.765,298.238,301.163,307.01300000000003,309.496,312.773,316.563,321.378,326.404,329.681,338.557,343.372,349.223,352.5,354.983,360.471,363.818,366.302,373.429,381.249,387.964,390.447,396.609,399.082,402.359,408.209,413.024,416.995,422.021,428.063,432.546,435.05899999999997,437.542,443.101,449.162,452.43899999999996,454.922,458.199,464.05,468.865,474.454,476.937,481.963,484.888,489.15,494.638,497.122,502.972,507.787,512.602" y="420.712" svg_rhmargin="518.744" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">malignancies could achieve a better response rate in treatment of CAR T therapy, but they also need</text>
  <text x="76.535,79.848,85.396,88.526,91.839,96.92,102.57,107.43799999999999,110.567,115.648,118.778,124.692,127.649,133.299,139.213,144.081,148.095,151.225,155.239,158.196,162.504,168.154,171.284,176.832,180.21599999999998,183.336,187.848,193.396,202.369,211.342,216.891,222.80499999999998,225.935,230.243,233.2,239.409,244.277,247.407,252.274,255.485,258.859,263.726,268.238,271.551,275.86,278.99,284.071,287.384,290.513,293.826,299.74,304.608,307.737,312.046,317.127,326.1,330.968,334.097,337.41,340.367,349.34,354.208,356.749,361.748,371.361,376.909,380.74,385.608,388.738,391.695,400.668,406.775,412.323,416.337,419.65,424.731,430.645,433.958,436.915,441.457,443.998,447.29,450.603,456.517,461.385,464.515,468.346,473.213,477.522,483.649,486.606,489.919,493.049,498.13,503.749,509.298,515.425" y="434.222" svg_rhmargin="518.738" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">to take a higher risk of common side effects at the same time. More importantly, the result about</text>
  <text x="76.535,83.297,90.05799999999999,92.538,98.064,101.43499999999999,103.915,111.092,118.966,125.72699999999999,128.208,134.413,136.893,140.192,146.083,150.932,154.93,159.991,166.074,171.702,174.182,178.474,184.365,189.891,198.333,203.182,209.367,211.846,215.146,221.037,226.098,229.39800000000002,231.877,235.177,241.068,245.91600000000003,248.396,255.158,261.919,264.399,269.926,273.29699999999997,275.776,281.86,286.921,290.221,293.166,298.015,303.906,307.205,311.49699999999996,313.977,322.419,325.364,328.664,334.555,337.035,342.926,347.774,356.712,361.773,365.073,370.599,373.545,379.071,384.699,387.645,392.139,394.619,403.557,408.618,411.563,414.509,420.136,426.027,431.088,436.979,441.474,444.419,449.267,453.55899999999997,456.039,464.481,469.542,473.83399999999995,476.313,480.605,483.551,492.488,495.434,498.379,503.44,507.438,509.918,513.208" y="447.731" svg_rhmargin="518.735" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">RR of CAR T therapy showed that the RR of patients with hematologic malignancies was similar to</text>
  <text x="76.236,82.259,87.271,90.538,93.454,98.255,104.088,107.355,111.604,114.101,122.459,125.376,128.643,134.476,136.972,141.221,146.693,149.61,152.526,158.649,161.146,169.995,175.007,177.923,180.84,186.412,192.245,197.256,203.089,207.539,210.456,215.256,219.506,222.012,224.507,232.866,238.699,241.615,246.065,251.898,254.394,263.243,268.044,273.055,278.888,283.137,285.623,288.891,294.724,299.735,303.002,305.498,311.331,316.803,319.299,328.148,333.16,336.427,339.694,344.495,348.454,350.949,354.217,360.05,364.851,367.346,373.369,378.381,381.648,384.564,389.365,395.198,398.465,402.714,405.21,413.569,416.486,419.753,425.586,428.082,432.331,437.803,440.72,443.636,449.759,452.255,457.728,461.687,464.182,470.015,474.816,483.666,488.677,491.944,497.416,500.333,505.805,511.378,514.294" y="461.24" svg_rhmargin="518.744" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">patients with solid malignancies, which means that no matter the patients with solid or hematologic</text>
  <text x="76.535,85.323,90.299,93.196,96.092,101.626,107.418,112.394,118.187,122.606,125.502,130.269,134.489,136.977,139.475,142.72,148.512,153.28,158.814,161.302,167.094,172.07,178.15099999999998,180.64,185.616,190.592,195.569,200.545,205.521,213.88199999999998,216.379,223.028,229.677,232.164,235.061,240.854,243.351,246.596,252.388,257.15500000000003,259.644,264.411,270.203,276.284,278.772,281.868,287.969,293.761,296.657,300.877,303.375,307.595,310.84,316.841,322.922,328.456,330.944,336.966,340.897,345.117,348.361,351.258,356.792,359.289,362.604,368.038,374.039,379.832,385.913,388.401,391.645,397.438,402.414,405.659,408.157,414.238,417.134,420.269,423.583,428.351,432.103,436.87,442.663,445.908,448.395,451.64,457.173,463.155,467.922,472.14200000000005,474.64,480.074,483.38800000000003,485.877,489.121,495.123,503.911,509.345,513.276,517.496" y="474.75" svg_rhmargin="519.984" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">malignancies, they had 25–30% RR in the end. This study ﬁrstly found that different types of tumors,</text>
  <text x="76.535,82.665,85.584,88.744,92.085,96.891,100.673,105.478,111.317,114.58699999999999,117.086,124.199,132.004,138.70499999999998,141.203,147.353,149.841,155.871,159.663,165.141,168.411,173.889,178.343,183.821,186.74,190.994,193.482,198.498,204.337,210.46699999999998,212.965,217.77,223.439,228.244,234.083,236.581,242.711,245.63,248.79,252.131,256.937,260.719,265.524,271.363,274.633,277.132,280.914,285.719,289.973,296.002,301.48,307.319,311.573,316.378,318.876,322.839,327.855,331.126,335.931,338.419,344.258,349.274,355.404,357.902,362.918,365.416,369.67,372.589,381.448,384.367,387.287,392.303,396.266,398.764,405.465,412.166,414.655,417.574,423.413,425.911,429.182,435.02,439.825,442.324,447.129,452.968,459.098,461.606,464.706,470.856,476.695,479.614,483.868,486.366,492.435,498.274,504.404,507.323,513.162" y="488.259" svg_rhmargin="518.74" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">different CAR T protocols and even different response rate had a similar RR in the end. This ﬁnding</text>
  <text x="76.117,84.426,89.407,93.631,96.122,101.103,104.351,107.599,111.534,114.433,119.942,125.95,129.198,133.97,140.057,142.548,145.795,151.23499999999999,153.726,156.973,162.772,167.54399999999998,170.034,172.934,178.732,183.155,186.054,192.062,196.286,199.185,204.625,210.423,212.913,218.353,221.67100000000002,224.161,229.79,234.771,238.707,241.606,247.045,253.053,257.277,259.768,263.015,268.555,274.542,279.314,283.538,286.029,291.469,294.787,297.277,300.525,306.532,315.329,320.769,324.704,328.928,331.419,334.318,340.116,342.607,345.854,351.653,356.425,358.915,363.14,368.121,376.918,381.69,384.181,392.978,397.75,400.997,405.979,409.296,414.278,420.076,425.057,427.956,433.495,437.72,440.619,444.843" y="501.768" svg_rhmargin="447.334" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">was attributed to the inclusion of various types of tumors in the same meta-analysis.</text>
  <text x="97.795,104.024,109.938,114.806,119.369,123.2,128.067,132.376,138.503,141.46,144.773,149.326,154.874,158.25799999999998,162.821,171.794,176.661,179.974,185.055,188.439,192.27,197.137,202.787,206.628,211.496,215.805,220.113,223.06,228.608,234.522,239.085,244.166,250.08,255.161,258.119,263.769,268.077,271.034,275.343,279.895,282.852,288.767,294.976,297.933,302.445,307.525,310.838,315.706,321.915,326.477,329.79,335.704,340.785,344.098,348.651,351.963,357.877,362.745,367.308,371.139,376.006,380.315,386.422,391.97,397.885,402.193,407.061,411.623,415.637,420.718,424.031,428.899,433.451,439.0,442.384,446.946,454.151,462.057,468.845,473.397,479.626,484.179,487.492,493.406,498.274,502.288,507.368,513.476" y="515.278" svg_rhmargin="519.126" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">The result of meta-regression analysis indicated that the response rate of CAR T therapy</text>
  <text x="76.535,82.449,87.53,93.739,96.859,101.94,106.248,110.557,116.105,120.617,123.574,128.655,131.968,134.925,140.473,146.387,149.507,157.982,160.939,164.252,170.166,173.286,178.367,182.879,187.746,190.703,193.66,196.77,201.282,207.409,210.367,213.679,219.807,223.648,228.516,231.635,240.11,243.067,246.38,252.29399999999998,255.414,258.839,265.047,268.431,273.512,276.622,281.703,287.912,294.121,297.078,300.39,303.348,308.896,314.81,319.891,323.011,328.092,334.006,340.215,343.334,348.415,351.728,357.276,360.589,365.67,368.627,371.747,376.828,383.037,392.01,394.967,400.881,403.838,408.147,411.459,415.473,420.554,423.867,426.824,432.373,438.287,443.368,445.909,450.877,457.015,460.856,465.724,471.465,474.422,479.971,486.098,490.40700000000004,493.516,497.825,501.138,507.265,513.474" y="528.787" svg_rhmargin="519.124" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">had association with “cell culture with IL-2 addition” and “total administration”. Previous study</text>
  <text x="76.535,80.216,84.892,89.227,94.558,103.179,111.8,116.477,122.159,128.125,132.801,138.766,140.944,144.127,149.809,154.691,157.874,160.06,164.395,169.824,173.007,178.337,183.766,186.607,192.289,196.966,201.106,203.283,207.618,212.949,218.836,221.677,227.642,229.829,235.229,239.905,242.092,247.979,252.119,256.796,262.76099999999997,264.938,267.779,273.461,275.649,278.49,287.111,292.979,296.65,301.98,307.497,310.338,316.02,321.448,323.636,326.818,332.501,337.17699999999996,339.364,344.041,349.079,354.947,359.828,365.511,369.65,372.491,377.822,383.504,385.682,391.012,394.263,396.451,402.357,406.214,410.354,413.537,415.714,421.142,425.819,431.501,436.178,440.034,444.916,448.099,450.94,456.271,461.95300000000003,464.14,471.062,478.658,485.18,489.32,491.76099999999997,494.006,498.888,504.57,510.53499999999997,512.713,515.554" y="542.297" svg_rhmargin="518.737" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">recommended that cytokines could be used in improving the expansion of ﬁrst generation CARs, and it</text>
  <text x="76.535,82.217,87.099,93.06400000000001,95.281,101.148,106.479,109.662,114.339,120.021,123.194,126.035,130.917,133.758,136.599,142.027,144.244,149.643,154.32,160.002,164.679,170.585,173.768,175.975,179.226,184.557,188.41299999999998,190.63,194.769,199.446,203.781,209.112,214.794,220.75900000000001,222.966,227.847,233.53,239.495,241.711,244.894,250.576,253.418,257.098,263.063,265.27,270.699,275.375,281.058,285.734,289.591,294.472,297.655,300.496,305.827,311.509,313.726,320.648,328.234,334.756,338.896,341.337,344.334,347.624,353.59,356.841,361.723,363.939,368.82,374.786,380.751,383.592,386.775,389.616,394.947,400.629,402.836,407.171,412.052,417.73400000000004,419.951,425.819,429.49,434.821,443.442,448.772,451.955,456.631,458.848,462.031,467.713,472.389,474.596,479.273,484.311,490.179,495.06,500.743,504.882,507.723,513.054" y="555.806" svg_rhmargin="518.736" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">had potentially beneﬁt for second and third generation CARs. IL-2 addition can promote the expansion</text>
  <text x="76.535,81.926,85.214,87.691,94.691,102.372,108.967,111.456,117.50800000000001,119.986,124.369,129.099,131.972,134.845,139.031,141.51,144.409,150.207,152.698,158.327,161.226,164.474,168.23,173.67,176.15,181.086,185.27200000000002,187.751,192.68800000000002,195.175,199.559,205.048,208.267,213.657,219.147,222.02,227.766,232.495,234.973,239.159,245.112,251.046,256.98,262.37,266.27,269.489,271.957,275.037,281.623,287.369,292.305,298.051,303.53999999999996,306.028,310.758,313.977,316.454,321.391,324.264,326.732,329.21,332.499,337.48,340.76800000000003,343.246,348.182,353.928,358.865,361.738,367.227,372.164,376.893,382.92499999999995,385.413,388.632,394.378,399.10699999999997,401.585,405.771,411.162,417.115,420.837,425.221,429.95,434.13599999999997,436.614,442.005,445.293,447.771,453.517,458.246,461.464,466.193,469.916,475.306,480.796,485.525,491.271,496.0,498.873,502.091,507.58,510.059,515.45" y="569.315" svg_rhmargin="518.738" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">of CAR T cells in vitro as a cytokine support. Zhang et al. [2] analyzed the sources of heterogeneity of</text>
  <text x="76.535,83.457,91.053,97.575,99.782,105.767,107.983,111.166,116.848,121.525,125.381,130.263,136.13,141.558,143.765,147.017,152.347,156.203,158.41,164.278,169.16,172.343,175.184,179.861,185.543,188.726,192.86599999999999,195.082,203.224,206.065,209.248,214.92999999999998,217.137,222.819,227.496,236.117,240.999,244.181,249.512,252.353,257.684,263.113,265.954,270.289,272.495,281.116,285.998,288.839,291.68,297.109,302.791,307.673,313.355,317.69,320.531,325.207,329.347,331.563,336.963,342.391,344.598,350.485,354.624,357.466,363.148,368.576,370.783,379.404,384.08,387.263,392.145,395.396,399.077,403.754,409.182,412.853,417.53,421.669,425.809,428.65,433.981,439.663,441.879,446.761,452.443,457.325,460.166,465.595,469.734,472.575,476.715,479.15599999999995,481.421,486.303,491.985,497.95,500.157,503.34,509.022,513.699" y="582.825" svg_rhmargin="519.127" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">CAR T therapy for patients with hematologic malignancies by using meta-regression analysis, and they</text>
  <text x="76.535,79.872,85.345,91.388,97.221,103.34400000000001,105.84,109.108,114.941,119.952,123.219,125.715,130.165,134.965,137.882,140.798,143.304,147.754,153.797,156.714,159.981,166.025,169.803,174.604,180.727,183.223,191.582,194.498,197.766,203.599,209.071,215.114,218.381,220.877,224.255,230.378,233.716,238.727,241.223,246.234,252.357,258.481,261.398,264.665,267.581,273.054,278.887,281.392,286.403,290.653,294.902,300.375,304.825,307.741,312.752,316.02,320.82,326.943,329.44,337.798,340.715,343.982,349.81500000000005,352.311,357.853,362.654,365.921,369.188,373.989,377.948,380.443,384.893,387.81,390.726,396.559,399.476,403.926,408.937,411.853,414.359,418.138,422.938,427.188,433.211,438.683,444.516,448.766,453.567,456.073,459.179,467.518,472.99,481.349,486.149,491.812,496.613,499.83,502.33599999999996,504.841,508.108,513.941" y="596.3340000000001" svg_rhmargin="518.742" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">found that cell cultured without IL-2 addition associated with better clinical response. However, the</text>
  <text x="76.535,79.437,85.241,89.669,92.571,98.584,104.678,109.454,115.54799999999999,118.031,122.259,125.51,131.524,137.617,140.519,145.296,149.525,152.007,157.452,160.773,163.256,169.908,175.712,180.698,186.502,192.047,194.53,199.307,202.558,205.031,210.018,212.92,215.41299999999998,218.504,226.821,231.598,235.358,240.135,242.618,247.604,250.506,253.408,255.891,261.885,267.898,273.413,276.315,279.217,283.446,289.25,294.027,300.121,302.603,308.118,312.895,316.215,321.66,325.42,330.197,332.67,337.656,342.643,347.629,352.615,355.108,357.602,362.588,368.392,374.486,376.958,381.187,386.632,395.437,400.214,402.697,406.926,410.177,416.19,422.284,425.186,429.962,434.191,436.674,442.478,447.464,453.558,456.041,461.028,463.51,467.738,472.725,481.53,486.30699999999996,488.79,493.777,499.79,503.041,508.845,514.29,517.491" y="609.844" svg_rhmargin="519.984" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">included studies of Zhang et al. were all published before 2015, and some studies had a same author,</text>
  <text x="76.535,79.848,85.762,91.89,96.199,99.409,102.722,108.636,113.504,116.461,120.475,123.686,127.517,132.385,136.693,142.821,145.778,149.091,153.4,156.61,162.525,167.606,173.815,177.026,181.334,186.883,195.855,200.72299999999998,203.934,206.891,209.848,218.821,221.778,225.091,230.172,233.485,236.442,241.99,247.904,252.213,254.754,259.997,266.226,272.14,277.008,280.219,284.05,288.918,293.226,299.354,302.311,305.624,309.93300000000005,313.144,318.692,322.076,325.287,328.6,334.514,337.471,341.78000000000003,344.991,349.299,352.612,358.74,364.949,370.599,373.8,377.184,383.311,387.325,390.638,396.552,401.42,405.434,408.645,411.602,417.516,423.725,426.682,431.194,436.275,439.588,444.456,447.666,450.979,456.893,461.974,465.287,468.498,473.01,477.877,480.835,483.792,487.003,491.515,497.642,500.599,503.912,510.04,513.871" y="623.3530000000001" svg_rhmargin="518.739" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">thus their results had some limitations. The results of this study further indicate that cell culture</text>
  <text x="76.117,84.592,87.549,90.862,96.776,102.324,108.452,111.765,114.539,117.964,124.172,127.556,132.637,135.422,140.503,146.711,152.92,155.877,159.19,162.147,167.696,173.60999999999999,176.384,184.859,189.94,194.249,197.033,202.114,206.422,210.731,216.279,220.791,223.748,228.829,232.142,237.01,243.219,245.993,254.468,257.425,260.738,266.652,269.436,275.35,278.307,283.957,289.872,294.739,298.753,301.527,306.039,308.996,311.953,317.867,320.825,325.336,330.417,333.37399999999997,336.149,339.99,344.857,349.166,355.273,360.822,366.736,371.044,375.912,378.686,382.7,387.781,391.094,395.961,400.27000000000004,403.054,406.011,411.925,414.7,420.807,425.888,429.201,432.158,437.025,442.939,446.252,450.56100000000004,453.335,461.81,464.767,468.08,473.99399999999997,476.778,481.087,486.635,489.592,492.55,498.759,501.533,506.614,512.528" y="636.862" svg_rhmargin="518.737" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">without IL-2 addition was associated with higher clinical response rates in patients with solid and</text>
  <text x="76.535,82.275,87.0,95.709,100.64,103.855,109.241,112.111,117.496,122.98,125.85,130.22899999999998,132.705,141.414,146.345,149.215,152.085,157.569,163.309,168.241,173.981,178.36,181.23,185.955,190.137,192.603,195.69,201.736,207.476,212.2,217.94,220.406,222.882,228.267,234.214,238.10999999999999,240.586,244.304,249.029,253.21,259.158,262.028,265.243,267.719,272.65,275.521,279.702,285.087,287.563,291.942,297.328,303.068,309.035,312.931,321.64,326.364,332.39,334.866,338.081,343.822,348.753,351.96799999999996,354.444,358.162,362.887,367.069,372.996,378.382,384.122,388.304,393.02799999999996,395.504,399.4,404.331,407.546,412.27,414.756,422.982,427.913,432.095,434.571,440.311,445.696,448.911,451.387,456.319,460.501,464.683,470.068,474.447,477.317,482.249,485.464,490.188,496.214,498.69,506.916,509.786,513.001" y="650.3720000000001" svg_rhmargin="518.741" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">hematologic malignancies. Then, our result also conﬁrmed that response rate was not associated with</text>
  <text x="76.535,82.549,85.413,88.514,91.792,96.507,100.217,104.932,110.661,113.87,116.36,121.833,126.548,132.276,136.991,140.879,145.801,149.009,151.874,157.248,162.977,165.477,172.446,180.104,186.679,190.852,193.31300000000002,195.813,199.022,204.751,210.686,214.859,217.35,220.558,226.287,231.002,233.502,239.231,243.946,248.66,254.674,257.165,260.442,265.817,269.705,272.195,275.404,281.133,285.84799999999996,288.348,293.269,299.283,305.297,308.162,311.37,314.235,319.609,325.33799999999997,327.828,333.202,336.48,338.98,342.297,348.311,351.589,356.511,359.001,362.21,367.584,370.074,374.445,380.38,383.244,386.453,392.389,396.099,400.81399999999996,403.304,407.675,412.39,415.254,418.118,422.291,424.792,428.503,433.217,441.909,446.83,449.695,455.423,459.596,462.087,465.296,470.67,473.16,478.604,483.31899999999996,485.819,489.992,493.201,499.136,505.15,508.015,512.73" y="663.881" svg_rhmargin="518.744" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">different generation CARs, thus the need for the addition of IL-2 to culture cells remains to be studied</text>
  <text x="76.535,81.561,87.412,93.554,96.036,101.716,106.531,110.502,113.427,119.508,124.323,130.465,132.978,136.064,141.091,146.338,151.826,155.104,160.13,163.055,165.538,170.564,176.706,185.582,188.507,194.358,197.283,201.545,204.822,208.793,213.819,217.096,220.021,225.51,231.35999999999999,233.843,239.985,245.473,249.736,254.551,259.577,262.06,267.086,272.936,279.078,281.561,286.587,292.629,297.444,301.414,305.676,308.602,312.864,316.141,320.956,326.806,331.269,336.084,341.11,343.593,346.492,352.29,354.781,360.41,363.309,368.938,374.378,376.86,385.244,390.059,393.848,398.663,401.146,404.423,410.274,415.762,421.824,427.413,433.263,436.53999999999996,439.023,444.049,448.311,450.794,454.071,462.455,467.943,470.426,476.015,480.83,486.419,488.902,492.25,497.276,501.739,505.016,510.505,514.475" y="677.391" svg_rhmargin="518.737" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">and veriﬁed. “Total administration dose” and “persistence” in vivo were thought as two key factors</text>
  <text x="76.535,79.919,85.467,89.481,92.327,96.158,101.025,105.334,111.441,116.989,122.904,127.212,132.08,134.925,138.939,144.02,147.333,152.201,155.035,160.116,166.03,172.239,175.085,181.873,188.661,191.506,197.044,200.428,203.274,210.478,218.384,225.172,228.018,234.247,237.082,240.395,246.309,251.177,255.191,260.271,266.379,270.921,273.462,276.398,280.229,285.097,289.405,295.513,300.38,304.892,308.205,311.162,316.903,321.771,324.728,329.27,331.811,335.957,343.944,350.072,354.086,356.921,360.762,365.629,369.938,376.066,379.023,382.336,386.64500000000004,389.479,392.863,398.991,403.005,406.318,412.232,417.099,421.113,423.958,428.47,434.019,439.933,446.081,450.095,459.068,463.935,470.144,472.989,476.302,482.216,487.297,490.61,493.445,498.526,501.839,507.387,510.7,515.781" y="690.9" svg_rhmargin="518.738" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">for response rate and RR of CAR T therapy, respectively. Our results further conﬁrmed that “total</text>
  <text x="76.535,81.476,87.515,96.242,99.117,104.869,107.745,111.936,115.157,119.061,124.003,127.224,130.1,135.496,141.24800000000002,143.729,149.767,155.163,159.354,164.088,169.03,171.51,177.262,182.203,188.242,190.722,195.663,201.41500000000002,203.906,208.847,213.038,217.228,222.614,227.002,229.878,234.82,238.041,240.917,246.313,252.065,254.556,262.798,265.674,268.896,274.648,277.128,280.854,285.588,289.778,295.718,301.114,306.866,311.056,315.78999999999996,318.271,322.175,327.116,330.338,335.072,337.543,340.023,345.488,351.448,354.66999999999996,357.15,360.026,363.248,365.729,369.919,375.878,381.373,386.868,391.602,395.792,399.014,403.748,409.787,412.267,415.489,421.241,426.182,429.404,431.885,435.107,440.503,443.724,448.666,451.542,454.022,458.964,465.002,473.729,476.605,482.357,485.233,489.423,492.645,496.548,501.49,504.712,507.588,512.984" y="704.409" svg_rhmargin="518.736" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">administration dose” had an association with response rate, but it suggested that total administration</text>
  <text x="76.535,82.5,87.831,91.971,96.647,98.669,101.51,106.186,110.326,114.466,116.487,119.669,125.352,130.233,135.915,137.937,142.818" y="717.919" svg_rhmargin="147.7" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">dose less than 10</text>
  <text svg_rhmargin="151.484" x="147.698,151.484" y="717.919" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:7.57px;font-style:NORMAL;font-weight:normal;">8 </text>
  <text x="154.003,158.338,163.015,165.856,168.697,172.837,174.858,177.699,182.375,188.34,190.362,193.545,198.87599999999998,200.896,205.778,207.799,213.198,217.875,221.058,224.241,228.917,232.773,234.795,238.466,243.142,247.282,253.15,258.481,264.163,268.303,272.979,275.0,278.857,283.738,286.921,291.598,294.039,296.157,304.3,309.982,312.823,317.158,322.84000000000003,324.862,333.004,337.886,342.026,344.047,348.382,353.712,359.395,362.578,366.434,371.316,375.172,380.6,382.612,385.795,391.12600000000003,393.147,398.477,404.365,408.221,410.242,413.083,418.414,424.096,429.525,432.776,436.916,440.099,444.98,450.663,456.628,459.469,465.151,470.579,472.601,478.469,483.145,486.826,491.161,495.838,501.705,504.888,507.729,513.06" y="717.919" svg_rhmargin="518.742" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">cells led to a better response rate, which was contrary to our long-standing perception</text>
 </g>
</svg>
